CA-REZZ NORISC ANTIBACTERIAL SKIN CARE- benzethonium chloride cream
FNC MEDICAL CORPORATION

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

FNC - CA-REZZ - NORISC CREAM - ANTIBACTERIAL SKIN CARE (60762-112)

ACTIVE INGREDIENT

BENZETHONIUM CHLORIDE 0.2%

PURPOSE

ANTIBACTERIAL

USES

CA-REZZ NORSIC CREAM IS A NON-GREASY ANTIBACTERIAL CREAM SPECIALLY FORMULATED TO SOOTHE SKIN TISSUE. IT IS IDEAL FOR USE ON IRRITATED SKIN. IT REDUCES COMMON GERMS THAT CAN CAUSE PAINFUL RASHES.

WARNINGS

FOR EXTERNAL USE ONLY. IF RASH OR IRRITATION DEVELOP, DISCONTINUE USE. CONSULT A PHYSICIAN IF IRRITATION PERSISTS.

KEEP OUT OF REACH OF CHILDREN.

DIRECTIONS

APPLY A SMALL AMOUNT OF CREAM TO SKIN AND RUB GENTLY.
USE AS A MASSAGE CREAM FOR IMMOBILE PATIENTS TO IMPROVE CIRCULATION.

OTHER INFORMATION

CA-REZZ NORSIC CREAM IS ENRICHED WITH VITAMINS A, D & E, ALOE VERA AND ALLANTOIN.

INACTIVE INGREDIENTS

DEIONIZED WATER, MINERAL OIL, ALOE VERA EXTRACT, PROPYLENE GLYCOL, STEARIC ACID, GLYCERYL STEARATE AND PEG 100 STEARATE, SAFFLOWER OIL, CETYL ALCOHOL, TRIETHANOLAMINE, SORBITAN, ISOSTEARATE, DIMETHICONE, ALLANTOIN, TOCOPHERYL ACETATE, RETINYL PALMITATE, ERGOCALCIFEROL, PHENOXYETHANOL, ETHYLHEXYLGLYCERIN, FRAGRANCE.

QUESTIONS/COMMENTS?

PLEASE CALL (800) 440-2888

Antibacterial Skin Care_Norisc Cream_120g_LBL

Antibacterial Skin Care_Norisc Cream_275g_LBL

CA-REZZ NORISC ANTIBACTERIAL SKIN CARE
benzethonium chloride cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:60762-112
Route of Administration	TOPICAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP)	BENZETHONIUM CHLORIDE	0.2 g in 100 g

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)
MINERAL OIL (UNII: T5L8T28FGP)
ALOE VERA WHOLE (UNII: KIZ4X2EHYX)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
STEARIC ACID (UNII: 4ELV7Z65AP)
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
PEG-100 STEARATE (UNII: YD01N1999R)
SAFFLOWER OIL (UNII: 65UEH262IS)
CETYL ALCOHOL (UNII: 936JST6JCN)
TROLAMINE (UNII: 9O3K93S3TK)
SORBITAN ISOSTEARATE (UNII: 01S2G2C1E4)
DIMETHICONE (UNII: 92RU3N3Y1O)
ALLANTOIN (UNII: 344S277G0Z)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
ERGOCALCIFEROL (UNII: VS041H42XC)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:60762-112-09	275 g in 1 TUBE; Type 0: Not a Combination Product	02/05/2018
2	NDC:60762-112-04	120 g in 1 TUBE; Type 0: Not a Combination Product	02/05/2018

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part333A	02/05/2018

Labeler - FNC MEDICAL CORPORATION (849207519)